Compare SIGA & ECBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SIGA | ECBK |
|---|---|---|
| Founded | 1995 | 1919 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 223.8M | 180.3M |
| IPO Year | 2016 | 2022 |
| Metric | SIGA | ECBK |
|---|---|---|
| Price | $2.66 | $20.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 499.5K | 5.4K |
| Earning Date | 11-09-2026 | 10-22-2026 |
| Dividend Yield | ★ 21.43% | N/A |
| EPS Growth | N/A | ★ 95.83 |
| EPS | 0.09 | ★ 1.17 |
| Revenue | N/A | ★ $598,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $194.92 | N/A |
| P/E Ratio | $30.89 | ★ $18.12 |
| Revenue Growth | N/A | ★ 3.64 |
| 52 Week Low | $2.66 | $15.88 |
| 52 Week High | $7.11 | $23.14 |
| Indicator | SIGA | ECBK |
|---|---|---|
| Relative Strength Index (RSI) | 33.92 | 46.23 |
| Support Level | N/A | $19.66 |
| Resistance Level | $3.43 | $20.61 |
| Average True Range (ATR) | 0.22 | 0.73 |
| MACD | -0.05 | -0.08 |
| Stochastic Oscillator | 7.25 | 2.94 |
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
ECB Bancorp Inc operates as a bank holding company. The firm, through its subsidiary, engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, multifamily real estate loans, construction and land loans, and home equity lines of credit.